Tzeng, Y. T., Chiang, A., & Li, C. (2026). Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Citazione stile Chigago Style (17a edizione)Tzeng, Yen-Dun Tony, An-Jen Chiang, e Chia-Jung Li. Targeting GCN5-mediated ERK Lactylation: A Promising Drug Development Frontier in Cancer Therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026.
Citatione MLA (9a ed.)Tzeng, Yen-Dun Tony, et al. Targeting GCN5-mediated ERK Lactylation: A Promising Drug Development Frontier in Cancer Therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.